Latest Food and Drug Administration Stories
WASHINGTON, June 11, 2013 /PRNewswire-USNewswire/ -- The Reagan-Udall Foundation for the FDA (RUF) is pleased to announce the appointment of the Steering Committee for its Innovation in Medical Evidence Development and Surveillance (IMEDS) program. IMEDS is a public-private partnership within RUF launched in April 2013 to advance the science and tools necessary to support post-market evidence generation on regulated products, including safety surveillance and evaluations, and to...
- Expands Questcor's Presence in Inflammatory and Autoimmune Disorders - ANAHEIM, Calif., June 11, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced it has acquired rights to develop Synacthen(®) and Synacthen Depot in the U.S. from Novartis Pharma AG and Novartis AG. Subject to certain closing conditions, Questcor has also acquired rights to Synacthen(®) and Synacthen Depot(®) in certain countries outside the U.S. Available in more than...
FALLS CHURCH, Va., June 11, 2013 /PRNewswire-iReach/ -- Dietary Supplement GMP Inspectional ReadinessA Comprehensive Road Map to 21 CFR 111**Virtual Conference**June 20, 2013 -- 10:00 a.m. - 3:00 p.m. EDTwww.fdanews.com/DietarySupplementsVC (Photo: http://photos.prnewswire.com/prnh/20130611/CG29414) FALLS CHURCH VA USA - MEDICAL INDUSTRY E-MAIL NEWS SERVICE (TM) - June 7, 2013 For an increasing number of dietary supplement manufacturers, the ominous results of increased FDA...
Clinovo Will Present its Open-Source Electronic Data Capture (EDC) System ClinCapture and its Latest eClinical Innovations at the Outsourcing in Clinical Trials: Medical Devices & Diagnostics Conference Sunnyvale, CA (PRWEB) June 10, 2013 Clinovo sponsors the Outsourcing in Clinical Trials: Medical Devices & Diagnostics conference, taking place June 12-13, 2013 in Saint-Paul, MN. Clinovo will present its latest eClinical technologies, including ClinCapture®, the most advanced...
Pradaxa lawsuit alleges Boehringer Ingelheim failed to provide adequate warnings regarding the risk of Pradaxa bleeding, including the fact that no effective agent to reverse the anticoagulation effects of pradaxa currently exists. Columbus, OH (PRWEB) June 10, 2013 The Pradaxa lawyers at Wright & Schulte LLC, an experienced law firm representing the victims of defective drugs, announce that they have filed a Pradaxa lawsuit on behalf of an Iowa man whose death was allegedly caused by...
The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) June 10, 2013 The prescription drug safety advocates at DrugRisk.com are alerting patients taking the blood thinner Pradaxa of updated information on the site. As the number of injury claims grows*****, a new study warns that patients may not be taking the drug correctly and there may be an added risk when...
Personal injury law firm to review claims regarding purportedly unsafe oral contraceptive Yaz. St. Louis, MO (PRWEB) June 10, 2013 The law firm of Page Bradley announced that it is now accepting cases against the makers of the oral contraceptive Yaz for allegedly misrepresenting its product. Page Bradley's lawyers are currently on standby to provide free consultations to those who may have been injured as a result of taking the purportedly unsafe contraceptive. According to...
The Michigan Actos lawyers at the dangerous drug law firm of Buckfire & Buckfire, P.C. are actively handling Actos lawsuits for patients diagnosed with bladder cancer. Southfield, MI (PRWEB) June 11, 2013 The dangerous drug legal team at the personal injury law firm of Buckfire & Buckfire, P.C. is now actively accepting Actos lawsuits for those patients allegedly suffering serious injuries after taking the prescribed diabetes drug. The dangerous drug lawyers are accepting all...
FREDERICK, Md., June 10, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, which has sold 500,000 devices, without prescriptions, in 57 countries reported that they have received three letters from the Office of Science Integrity. These letters are virtually identical in denying the firm's request for the FDA Commissioner to review her staffs' prior decisions. Dr. Jesse Goodman, Chief Scientist, said, "I have...
- New label revises product's indication and provides new dosing guidelines. NASHVILLE, Tenn., June 10, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Acetadote (acetylcysteine) Injection. The new labeling revises the product's indication and offers new dosing guidance for specific patient populations. Acetadote is free of EDTA or any other stabilization or...
Latest Food and Drug Administration Reference Libraries
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
